Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer
Yoojeong Seo(Yonsei University), Tae Il Kim(University of Ulsan)
Cited by 59
Related Papers
Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism
|Scientific Reports|2018|98
Bortezomib induces G2-M arrest in human colon cancer cells through ROS-inducible phosphorylation of ATM-CHK1
|International Journal of Oncology|2012|61
MRI assessment of glutamine uptake correlates with the distribution of glutamine transporters and cancer stem cell markers
|Scientific Reports|2022|13
Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance
|Oncology Reports|2021|4